HyperLink
SEARCH:
Search

 
For Information on Physicians and Services, call 1-800-926-UCSD

About Us
Appointments
Care Centers and Departments
Blood & Marrow Transplant
Brain Tumor Unit
Diagnosis and Treatment
Frequently Asked Questions
Breast Cancer Unit
Cancer Genetics Unit
Gastrointestinal Cancer Unit
Gynecological Cancer Unit
Head & Neck Cancer Unit
HIPEC - Heated Intraperitoneal Chemotherapy
Imaging/Diagnostic Radiology
Infusion Center
Laboratory & Phlebotomy
Leukemias & Lymphomas
Lung Cancer Unit
Melanoma Unit
Multispecialty Clinic
Pancreatic Cancer Program
Pharmacy
Procedure Suite
Radiation Oncology
Soft Tissue Tumor Unit
Urologic Cancer Unit
Clinical Trials
Health Information
New Patient Orientation
Prevention Programs
Support Services for Patients & Families
Types of Cancer

FAQs about Brain Tumor Treatments

What is stereotactic radiosurgery?

Stereotactic Radiosurgery (SRS) is a treatment technique that delivers a highly focused dose of high-energy radiation to the tumor. The tumor is first localized with MRI and/or CT-based computer imaging equipment, and beams of focused radiation from a LINAC or Gamma Knife machine are used to treat it. The procedure is completed in one day and the actual treatment typically takes less than 30 minutes. A sharp radiation dose gradient is produced at the treatment field edges resulting in a highly effective treatment of the lesion target, while greatly reducing the dose of radiation to the surrounding healthy tissue. This non-invasive treatment often avoids complications and inconveniences of open surgery.

What is Conformal Fractionated Stereotactic Radiation Therapy?

Stereotactic Radiotherapy (SRT) accurately delivers lower doses of focused radiation over a series of treatment sessions called "fractions." By treating the lesion with multiple fractions of a lower dosage of radiation, spaced over weeks of treatment, the SRT method enhances the biological effect on the tumor while decreasing the chances of radiation damage to nearby critical structures. This technique is particularly important in cases where tumors are adjacent to radiosensitive tissues such as the brain stem, eyes or optic nerves, or in pediatric tumors.